Skip to main content

Duplicate Patients

A Proactive Solution for Preventing Enrolment Abuse

Duplicate Patients in Clinical Trials
1
Surface Potential Duplicates

Obtain a prioritized list of potential duplicate patients.

2
Analyze

Drill down to review the clinical data for each patient pair.

3
Configure Analysis

Tell the system which variables to use for duplicate detection.

Hover over the toggles to discover the features.
FIND DUPLICATE PATIENTS

Duplicate Patients has the power to identify professional patients within your trial. Specify the data points likely to lead to duplicate identification and the platform will present you with a prioritised listing of patient ‘pairs’ for review and confirmation.

Connect with an Expert
Duplicate Patients in Clinical Trials
1
Surface Potential Duplicates

Obtain a prioritized list of potential duplicate patients.

2
Analyze

Drill down to review the clinical data for each patient pair.

3
Configure Analysis

Tell the system which variables to use for duplicate detection.

Hover over the toggles to discover the features.
  • Improve patient safety and data integrity by detecting duplicate patients automatically.
  • Analyze patient data to find potential patient ‘pairs’, using a configurable number of variables (>=5 variables) from the patient record to identify matches (e.g Age, sex, height, weight, country, race etc.,)
  • Our duplicate patient analysis dashboard offers a convenient way to review and process the analysis results.
  • Prioritize the potential duplicate patients by their ‘similarity score’ in order to review the patients that are most likely duplicates first.
  • Drill down and compare duplicate patient records side-by-side.
  • For trials with study sites relatively close to one another, the likelihood of duplicate patients increases due to the accessibility of various study sites. For example, in North America, the states of California, Florida, Pennsylvania & New York are hubs for clinical research and investigation sites.

Got a Question?

Whether you’re looking to get started or need support, we’re here to help!

Featured Whitepaper

ICH E6 (R2)
Summary
Paper

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)
Webinar
Series

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.

7,000

Platform Users

1,200

Studies De-Risked

100,000

Issues Detected